In this medical video learn more about predicting prostate cancer.
Read the full transcript »
Ray Halligan: It wasn't something I would want every year. Jennifer Matthews: Each year, over one million men, like Ray, have pieces snipped from their prostate gland. Ray Halligan: It was like getting punched in the leg really quick with a finger. Jennifer Matthews: Biopsies carry a small risk of infection and bleeding and cost more than $700 a piece. Dr. Mark Garzotto: The vast majority of men who undergo a biopsy do so unecessarily. Jennifer Matthews: In fact, only one quarter of the men who have a biopsy have cancer. If a man has an elevated blood protein called PSA, doctors generally recommend a biopsy. Doctor Mark Garzotto says this mathematical formula is a better predictor. Dr. Mark Garzotto: We can find a patient that has a very high risk of having prostate cancer and separate him away from a patient that has a very low risk of having prostate cancer. Jennifer Matthews: The nomogram is a formula that looks at four factors: the patient's age, digital rectal exam, ultrasound finding, and PSA density -- or the PSA blood level in relation to the size of the prostate. This man's prostate is five-times normal size, but according to doctor Garzotto's calculations, his cancer risk is less than 5 percent. Doctor Garzotto says the nomogram predicts prostate cancer accurately 92 percent of the time. In the future, it could eliminate 200,000 unnecessary biopsies each year. This is Jennifer Matthews reporting.
Copyright © 2005 - 2014 Healthline Networks, Inc. All rights reserved for Healthline.